In order to test whether splicing inhibition of MCL1 would selectively inhibit the MCL1-amplified/dependent NSCLC lines in vivo, we performed antitumor efficacy studies in three xenograft models: MCL1-dependent H1568 and H2110 and MCL1-independent A549. Here, MCL1 is linked to non-small cell lung carcinoma.